Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
- PMID: 35724868
- PMCID: PMC9212580
- DOI: 10.1016/j.cmi.2022.06.007
Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
Comment on
-
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis.Clin Microbiol Infect. 2022 Oct;28(10):1382-1388. doi: 10.1016/j.cmi.2022.05.009. Epub 2022 May 17. Clin Microbiol Infect. 2022. PMID: 35595128 Free PMC article.
-
Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination.Clin Microbiol Infect. 2022 Nov;28(11):1513. doi: 10.1016/j.cmi.2022.05.033. Epub 2022 Jun 13. Clin Microbiol Infect. 2022. PMID: 35709905 Free PMC article. No abstract available.
References
-
- Pereson J.M., Amaya L., Neukam K., Baré P., Echegoyen N., Badano M.N., et al. Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination induces a stronger humoral response than homologous Sputnik V in a real-world data analysis. Clin Microbiol Infect. 2022;28:1382–1388. doi: 10.1016/j.cmi.2022.05.009. - DOI - PMC - PubMed
-
- Laham Gustavo, Martínez Alfredo P., Gimenez Wanda Rojas, Lucas Amaya, Abib Anabel, Echegoyen Natalia, et al. Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients [e-pub ahead of print] MedRxiv. 2022 doi: 10.1101/2022.05.13.22275049. Accessed on May 19th. - DOI - PMC - PubMed
-
- Macchia A., Ferrante D., Bouzas M.B., Angeleri P., Biscayart C., Geffner J., et al. Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: results of two randomized clinical trials. Lancet Reg Health Am. 2022;9 - PMC - PubMed